Why it is studied
HGH Fragment 176–191 is a synthetic sequence associated with the C-terminal region of human growth hormone. It has mainly been investigated in preclinical models concerning lipid metabolism and adipocyte signalling.

Presentation mock-up for HGH Fragment 176–191 — 5 mg. The batch, COA and final commercial packaging will be confirmed before launch.
A synthetic fragment corresponding to a region of the human growth hormone sequence; identity must be confirmed by batch documentation.
The price is published for catalogue purposes. Any quote or sale depends on product availability, batch-document verification and buyer-eligibility checks.
HGH Fragment 176–191 is a synthetic sequence associated with the C-terminal region of human growth hormone. It has mainly been investigated in preclinical models concerning lipid metabolism and adipocyte signalling.
Research attempts to isolate the activity of a limited region of the HGH sequence without assuming that the fragment reproduces the full profile of recombinant growth hormone.
Public clinical evidence is limited. Claims about personal outcomes cannot be inferred from preclinical studies or from the fragment’s commercial name.
This summary is informational and describes research context; it is not a medical claim or recommendation for use.
Exact storage and handling conditions must come exclusively from the verified batch data sheet and COA.
No reconstitution, dosing, injection, human-use instructions are provided.
No certificate is published for this product in the staging version. A COA will appear only if it is authentic, verified and linked to the batch offered.
Conditions depend on product classification, transport requirements and destination eligibility. See our delivery and returns page.
Scientific context for Retatrutide, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for MOTS-c, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for NAD+, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →
An investigational peptide analogue studied in activity models involving GIP, GLP-1 and glucagon receptors.
10 mg

A 20 mg configuration of the investigational peptide analogue studied in multi-receptor models.
20 mg

A mitochondrial-derived peptide used in research on energy signalling and cellular responses.
10 mg
No. Products labelled RUO are exclusively for research and are not intended for use in humans.
Prices are visible, but sale remains blocked until each product passes legal review, its documentation is checked and buyer eligibility is confirmed.
Yes, but only when they are authentic, batch-linked and verifiable. We do not publish generic certificates or invented percentages.
Add products to the cart and complete the professional eligibility form. An enquiry does not guarantee a sale.
The content and catalogue are intended for eligible professionals, laboratories and research organisations.
Read the full noticeReceive a code for the first order that passes eligibility and legal-availability checks.